Sanofi to pay $125M up­front for two im­munol­o­gy drugs from lit­tle-known biotech

Sanofi is team­ing up with a pri­vate biotech in Delaware on a pair of bis­pe­cif­ic an­ti­bod­ies for au­toim­mune and in­flam­ma­to­ry bow­el dis­eases.

Sanofi will give …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER